Skip to content
All bills in Congress

H.R. 3162 · 119th Congress · Health

Affordable and Safe Prescription Drug Importation Act of 2025

A bill that started in the House. To become law it must pass the House and the Senate in identical form and be signed by the President.

Where it stands

In committee in the House

  1. Introduced — doneMay 1, 2025
  2. Committee — not yet
  3. Passed the House — not yet
  4. Passed the Senate — not yet
  5. Sent to the President — not yet
  6. Became law — not yet

Latest action · May 1, 2025
Referred to the House Committee on Energy and Commerce.

What this bill means

In plain English

This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported.

From the official summary by the Congressional Research Service (introduced in house version). The full summary is below.

If it passes

It becomes federal law, and what it describes takes effect on the dates written into the bill.

What still has to happen

  1. 1A House committee must take it up and approve it. Most bills never get past this step.
  2. 2Then the full House must pass it.
  3. 3Then the Senate must pass it in the same form.
  4. 4Then it goes to the President to sign or veto.

If it doesn't pass

  • Nothing changes. The law stays exactly as it is today — a bill has no effect unless it is enacted.
  • This bill expires when the 119th Congress ends on Jan 3, 2027. To try again, a member would have to introduce it as a new bill in the next Congress and start over.
Read the full official summaryCongressional Research Service · Introduced in House · May 1, 2025

This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported.

Current law allows the Department of Health and Human Services (HHS) to authorize importation of certain eligible prescription drugs from Canada if HHS certifies that doing so would pose no additional risk to public health and safety, among other requirements. HHS long declined to make the requisite certification, citing safety concerns (e.g., contamination, counterfeiting), but ultimately made the certification in 2020 and has since approved one state plan to import drugs.

The bill removes the certification requirement and requires HHS to issue regulations that permit importation of qualifying prescription drugs from the United Kingdom, Switzerland, and member states of the European Union, in addition to Canada. After one year, if HHS determines that importation of drugs from these countries has been conducted safely, HHS may authorize importation from other countries that meet certain requirements.

The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin.

Further, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS.

Finally, the bill imposes criminal penalties for websites that sell counterfeit drugs or dispense drugs without a required prescription.

Who started it

Sponsor — the member who introduced it

Janice D. Schakowsky

DemocratRepresentative from Illinois, District 9

Introduced in the House on May 1, 2025.

See Janice D. Schakowsky's votes and donors

Cosponsors — members who signed on in support

10cosponsors

10 Democrats · 0 Republicans

Every cosponsor so far is a Democrat.

Show all 10 cosponsors

Committees handling it

A bill is sent to the committee that covers its subject. The committee decides whether it ever reaches a vote of the full chamber.

  • Energy and Commerce Committee

    House

    • Referred To · May 1, 2025

Full timeline

Every recorded action on H.R. 3162, from the day it was introduced to the most recent, exactly as the House, the Senate, and the Library of Congress logged it.

  1. IntroducedHouse

    Introduced in House

  2. House

    Referred to the House Committee on Energy and Commerce.

Have a view on H.R. 3162? Your leaders vote on it.

Tell your senators and your representative where you stand. We fill in who represents you and reference this bill in the letter.

Write your leaders about thisSource: Congress.gov record for H.R. 3162(opens in new tab)